Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Beetroot juice to boost blood vessels, insulin sensitivity, and exercise in prediabetes on vs. off metformin

Official title: The Interaction Between Inorganic Nitrate Supplementation and Metformin on Exercise Capacity, Vascular Function, and Insulin Sensitivity in Individuals With Pre-Diabetes

Run by University of Virginia · NCT07131384 · Data updated 2026-11-12

In people with prediabetes, this study tests whether short-term inorganic nitrate from beetroot juice can improve blood vessel health, insulin sensitivity, and exercise capacity, and compares those already taking metformin with those who are not.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment24 (estimated)
SponsorUniversity of Virginia
Academic / other
Locations1 site (Charlottesville, Virginia)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedJune 1, 2027
Study endsJune 30, 2027
Registry record updatedJune 3, 2026
Trial IDNCT07131384 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-60 with prediabetes who are sedentary and either currently taking metformin or naïve to metformin.

Probably not a fit

Individuals outside the prediabetes range or those with significant kidney impairment, high BMI, or other exclusions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double-blind cross-over study involving 24 adults with prediabetes. Participants will receive inorganic nitrate (beetroot juice) or nitrate-depleted placebo in alternating periods, and will be categorized as metformin users or metformin-naïve. The study will measure vascular function, VO2 peak, lactate threshold, glucose tolerance, and endurance during exercise. It aims to see if nitrate supplementation can enhance vascular and metabolic responses without adverse effects in this population.

Why it matters

Potential benefit: If successful, beetroot nitrate could offer a simple dietary approach to improve vascular health and insulin sensitivity in prediabetes.

How similar studies have gone: Prior work suggests nitrate supplementation can enhance vascular function, with this study extending to prediabetes and metformin status; the exact benefits in this context remain to be proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals who can communicate meaningfully with the investigator and can provide written consent.
* Confirmed prediabetic individuals (ages 18-60 years old) (2-hour glucose of 140-199 mg/dL following OGTT test or HbA1c between 5.7-6.4% tested on two occasions within 6 months).
* Taking metformin (stable dose for at least a week) or naïve to metformin
* Sedentary (\<1 day/week of structured exercise)
* Be able to perform exercise on a cycle ergometer without assistance
* Stable medication regimen for the last 6 months
* If female, have a normal menstrual cycle

Exclusion Criteria:

* Estimated Glomerular filtration rate (GFR) ≤ 45
* Body mass index ≥ 40 Kg/m2
* HbA1c \> 6.4%
* Smokers within the last 5 years
* Has experienced significant weight loss \~3 kg in the last three months or is taking any weight loss drugs
* Current medical condition that prohibits exercising at high intensities
* Currently on hormone replacement of any kind
* History of myocardial infarction, cerebrovascular event, acute or unstable disease other than pre-diabetes or obesity
* Currently taking any of the following medications (calcium channel blockers, statins, ACE or renin inhibitors, angiotensin receptor blockers, organic nitrates (e.g., nitroglycerine) or recent regular use of inorganic nitrates, alpha- or beta-blockers, diuretics, proton pump inhibitors, PDE-5 inhibitors (e.g.,: Cialis, Viagra), or xanthine oxidase inhibitors (e.g.,: Allopurinol))
* Oral antibiotic use within the previous four weeks, including over-the-counter antibacterial mouthwash or a mouthwash containing chlorhexidine and unwilling to discontinue use
* Oral cancer/severe oral disease
* Uncontrolled hypertension (\>140/90)
* Had hysterectomy or oophorectomy
* Fetuses, neonates, children, prisoners, cognitively impaired, non-English speaking participants

Where it's running

  • University of Virginia
    Charlottesville, Virginia, United States
    Recruiting

Study contacts

  • Principal investigator: Jason Allen, PhD — University of Virginia
  • Study coordinator: Money Ghimire, M.S
  • Email: eta8xd@uvahealth.org
  • Phone: 4342438677

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.